US-Backed Hepatitis B Vaccine Trial in Guinea-Bissau Halted
A controversial US-funded Hepatitis B vaccine trial in Guinea-Bissau, designed to involve 14,000 newborns, has been canceled due to a lack of governmental approval and widespread ethical concerns.
PrimaryBrief newsroom12 sources